Glucagon News and Research

RSS

The microbiota connection, gut health linked to metabolic syndrome prevalence

The relationship between gut microbiota and metabolic disorders focused on BA metabolism and immunity.

1 Aug 2023

How the brain keeps blood sugar levels in check

The body's blood glucose level needs to be maintained in a relatively narrow range. It cannot be too high, as it can lead to diabetes, and it cannot be too low because it can cause fainting or even death.

11 Jul 2023

New study shows circulating anti-insulin CD4 T cells reflect progression of anti-islet immunity

In a recent study published in Science Translational Medicine, researchers profile antigen-specific helper clusters of differentiation 4-positive (CD4+) T-lymphocytes to determine anti-islet autoimmunity among mice and humans.

9 Jul 2023

Timing, type, and frequency of exercise are crucial components for optimal glycemic control in type 2 diabetes

Exercise plays a crucial role in managing type 2 diabetes, offering potential benefits such as improved glycemic control. This study explores exercise recommendations and their impact on dietary, medication, and behavioral factors for optimal diabetes care.

5 Jul 2023

Researchers uncover the role of glutaminase 2 in glucose homeostasis

Glutaminase 2 (GLS2) is a master regulator of glutaminolysis. GLS2 converts glutamine to glutamate, thereby playing a role in cellular energy production. GLS2 is abundant in the liver, and is also found in pancreatic β-cells. However, the role of GLS2 in pancreatic islets – in which both ɑ- and β- cells are present – associated with glucose metabolism is currently unknown.

5 Jul 2023

TOS members unveil new research about anti-obesity medications at ADA annual meeting

Multiple members of The Obesity Society (TOS) unveiled new research about several anti-obesity medications in development at this year's annual meeting of the American Diabetes Association (ADA) held June 23–26.

29 Jun 2023

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

Researchers performed a double-blinded, placebo-controlled phase III randomized clinical trial (RCT).

29 Jun 2023

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Researchers performed a phase II randomized clinical trial (RCT).

29 Jun 2023

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Researchers performed a phase III randomized clinical trial (RCT).

29 Jun 2023

Higher doses of oral semaglutide effective in lowering blood sugar and promoting weight loss

Diabetes is a progressive disease that affects one's ability to control blood sugar levels. For many patients, the condition becomes more severe over time and blood sugar levels grow more difficult to manage.

26 Jun 2023

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Researchers evaluated the effectiveness of diabetic diets containing D-allulose among type 2 diabetes patients.

21 Jun 2023

Carb conundrum: debunking the link between pasta and obesity

Researchers reviewed existing data on the impact of diet patterns with high pasta content on body weight.

13 Jun 2023

Study reveals intricate pathway that dictates the cell’s ability to be resilient and plastic

Researchers have long thought that once a cell starts down its path of differentiation, growing into a skin cell or a liver cell or a neuron, that path could not be changed.

7 Jun 2023

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

Orally administered semaglutide shows significant efficacy in reducing HbA1c and body weight in patients with type 2 diabetes compared to other treatments. The study includes a large number of participants from multiple trials.

7 Jun 2023

How does tirzepatide stimulate insulin secretion?

Tirzepatide, a drug approved for diabetes and on the fast track for approval as a weight loss therapy, works through a unique ability to activate two different mechanisms the body uses to control insulin secretion and energy balance, Duke Health researchers report.

6 Jun 2023

Targeting stem cells from the human stomach for treating diabetes

Stem cells from the human stomach can be converted into cells that secrete insulin in response to rising blood sugar levels, offering a promising approach to treating diabetes, according to a preclinical study from researchers at Weill Cornell Medicine.

25 May 2023

Glucagon News and Research

The microbiota connection, gut health linked to metabolic syndrome prevalence

How the brain keeps blood sugar levels in check

New study shows circulating anti-insulin CD4 T cells reflect progression of anti-islet immunity

Timing, type, and frequency of exercise are crucial components for optimal glycemic control in type 2 diabetes

Researchers uncover the role of glutaminase 2 in glucose homeostasis

TOS members unveil new research about anti-obesity medications at ADA annual meeting

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Higher doses of oral semaglutide effective in lowering blood sugar and promoting weight loss

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Carb conundrum: debunking the link between pasta and obesity

Study reveals intricate pathway that dictates the cell’s ability to be resilient and plastic

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

How does tirzepatide stimulate insulin secretion?

Targeting stem cells from the human stomach for treating diabetes

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

Tirzepatide improves body composition across a range of adult age groups, study shows

Researchers find that SARS-CoV-2 directly infects hepatocytes that cause hyperglycemia

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News